PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy  

  vs.

Standard of care (SSRI’s, SNRI’s, MAOI’s, NDRI’s, etc…) which  just chemically treat symptoms. Working in partnership with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants.

3 primary breakthroughs for the treatment of mental health issues. 

​

1. Discovered an efficient, patent-pending bacterial biosynthesis process for tryptamine production.

​

2. Developing a portfolio of tryptamine-derived, psychedelically inspired molecules.

​

3. Demonstrated the entourage effect of certain tryptamines in a laboratory-controlled environment.